RANBP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, the levels of RanBP3, p-RanBP3, and p(ser112)-BAD were down-regulated in CML cells after treating with U0126 for 6h (Supplementary Figure 3B).